CRISPR Therapeutics and Vertex Pharmaceuticals announced that the U.S. FDA has placed a clinical hold on the new-drug application for a drug used for the treatment of sickle-cell disease.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.